Tremelimumab
INFORMATION ABOUT TREMELIMUMAB
Tremelimumab Uses
Tremelimumab is used in the treatment of non-small cell lung cancer and liver cancer.
How Tremelimumab works
Tremelimumab is an immunotherapy that improves the body's anti-cancer defences. It inhibits CTLA-4, a protein that typically lowers immune cell activity. Tremelimumab enables immune cells to remain active and combat cancer cells by inhibiting this protein.
Common side effects of Tremelimumab
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common
Increased liver enzymes, Decreased hemoglobin, Decreased sodium level in blood, Increased bilirubin in the blood, Increased alkaline phosphatase level in blood, Decreased white blood cell count (lymphocytes), Nausea, Fatigue, Musculoskeletal (bone, muscle or joint) pain, Decreased appetite, Rash, Diarrhea
CONTENT DETAILS
Last updated
29 Dec 2025 | 06:29 AM (UTC)
We provide you with authentic, trustworthy and revelant information
Read our editorial policy
Medicine brands for Tremelimumab
Expert advice for Tremelimumab
- If you face diarrhea while having Tremelimumab, it could be an early sign of colitis, which may need urgent treatment.
- Thyroid and adrenal problems may develop silently. Blood tests are essential to detect them early.
- If severe side effects occur, your doctor may start corticosteroids; never stop them suddenly without medical advice.
- Use reliable contraception during Tremelimumab treatment and for 3 months afterward to avoid harm to the fetus.
Frequently asked questions for Tremelimumab
The infusion order matters. Tremelimumab is given first, followed by durvalumab, as this sequence helps the immune system respond better.
Each dose of Tremelimumab is given as an intravenous infusion usually over about 60 minutes.
No. In most regimens, Tremelimumab is given for only a few doses at the beginning, while durvalumab continues for a longer period.
Some patients may experience infusion-related reactions like fever, chills, rash, or breathing trouble. Nurses will monitor you during and after the infusion.
Yes. Doctors check liver enzymes, kidney function, and thyroid hormones before each dose to detect problems early.